Toxic oil and pathomechanisms
Pilar Escribano-Subias (Madrid)

Dasatinib-induced PAH and possible roles of other TKI
Olivier Sitbon (Paris-Saclay)

TKI’s & PAH: data from the bench (benefits and risks)        
Christophe Guignabert (Paris-Saclay)

Predicting Safer TKI’s Through Transcriptomics
Adam Andruska (Stanford)

Agents inducing PVOD: alkylating agents and solvents       
Marc Humbert (Paris-Saclay)